
Oscar Calvillo
@oscaar84
Cardiologist. Cardio-Oncologist. Advanced HF/ Heart Transplant Specialist. #echofirst.Tec de Monterrey (EMIS 26)/UNAM/UofT/NOSM University #Rayados🇲🇽🇨🇦
ID: 853948645
http://page.is/oscaar84 30-09-2012 02:09:49
975 Tweet
781 Takipçi
1,1K Takip Edilen


Results to be expected end of 2025 - Meanwhile ACHLYS trial design protocol- AbataCept dose-finding pHase II triaL for immune checkpoint inhibitors myocarditis and tappering immunosuppression strategy available 👉 sciencedirect.com/science/articl… UNICO-GRECO cardio-oncology program




Como los veo muy animados… Ahí les va, sin anestesia toda la info de Rayados y lo que ocurrirá para que reflexionen este finde 😂 Lunes los veo en #antidoping con cada detalle en RG La Deportiva /Multimedios Deportes — Demichelis priorizó sistema sobre hombres… ❗️Ya apaguen la lumbre. No

Thanks Bishal! It was sad to see a metastatic HSPC trial enrolling patients to a control arm of ADT when 4 different life prolonging therapies were already approved before it started enrolling! WE MUST DO BETTER FOR OUR PATIENTS! Journal of Clinical Oncology

Heart attacks or #heartfailure in #breastcancer survivors are assoc w/ increased cancer mortality, second malignancies & new #chemotherapy although the association may not be entirely causal jacc.org/doi/10.1016/j.… #CardioOnc #JACCCardioOnc #BCsm #cvMI Oscar Calvillo Husam Abdel-Qadir






People with #AFib & malignancy generally had similar hazards of #stroke but higher hazards of bleeding vs cancer-free control subjects, suggesting that malignancy should not lower the threshold for anticoagulation in AF. jacc.org/doi/10.1016/j.… #JACCCardioOnc #cvCoag Husam Abdel-Qadir


Recap #ACC25 #AF in cancer patients by Daniel Addison, MD ✅ Driven by inflammation, therapies & CV risks ⚠️ Worsens survival 🩺 Novel therapies linked to AF: ▪️ BTK inhibitors (i.e ibrutinib) ▪️ ICI, CAR-T, BiTE therapies 🔎 #whyCMR predicts outcomes in ibrutinib-associated AF


Fomentar la presentación de trabajos por MPSS y residentes es parte de su formación. Ahora los médicos pasantes pueden realizar su pasantía y los cardiólogos una alta especialidad en CCA. Si estás interesado en nuestro programa escribe a [email protected]





Jennifer Liu JACC Journals Kazuhiro Sase dineshpmcc International Cardio-Oncology Society Congratulations, really important work that addresses a key questions in our field. This study nicely sets the stage for the JUSTIFY RCT (NCT06930521) which we hope will demonstrate that less frequent mandatory imaging is not only safe, but superior to SOC clinicaltrials.gov/study/NCT06930…